Concepedia

Samira Syed

SS

Statistics

Publications

13

Citations

431

H-Index

12

Active since

1996

Affiliations

The University of Texas at San Antonio Health Science Center(Current)

Baylor College of Medicine

Brooke Army Medical Center

Parkland Health & Hospital System

The University of Texas Southwestern Medical Center

Samira Syed is an author at The University of Texas at San Antonio Health Science Center specializing in medicine, oncology, and pharmacology.

ORCID

Publications per year

1996–2020

13

Publications

13

Phase I and Pharmacokinetic Study of Tasidotin Hydrochloride (ILX651), a Third-Generation Dolastatin-15 Analogue, Administered Weekly for 3 Weeks Every 28 Days in Patients with Advanced Solid Tumors

Alain C. Mita, Lisa A. Hammond, Peter L. Bonate et al. · Clinical Cancer Research · 2006 · 67 citations · Full text

, , +11

A Phase I and Pharmacokinetic Study of Col-3 (Metastat), an Oral Tetracycline Derivative with Potent Matrix Metalloproteinase and Antitumor Properties

Samira Syed, Chris H. Takimoto, Manuel Hidalgo et al. · Clinical Cancer Research · 2004 · 65 citations

, , +15

A phase II and pharmacological study of the matrix metalloproteinase inhibitor (MMPI) COL-3 in patients with advanced soft tissue sarcomas

Quincy Chu, Bahram Forouzesh, Samira Syed et al. · Investigational New Drugs · 2007 · 61 citations

, , +14

Transgenic Expression of the Human MRP2 Transporter Reduces Cisplatin Accumulation and Nephrotoxicity in Mrp2-Null Mice

Wen Xia, Brian Buckley, Elizabeth McCandlish et al. · American Journal Of Pathology · 2014 · 60 citations · Full text

, , +15

Multidisciplinary Teams Improve Gastric Cancer Treatment Efficiency at a Large Safety Net Hospital

Michelle R. Ju, Sam C. Wang, Samira Syed et al. · Annals of Surgical Oncology · 2019 · 30 citations

, , +12

1–5 of 13